1861 studies found for:    Farber's Disease
Show Display Options
Rank Status Study
21 Active, not recruiting
Has Results
Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Interleukin-2
22 Completed
Has Results
Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: bortezomib;   Drug: Prednisone
23 Active, not recruiting Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Bortezomib;   Drug: Sirolimus
24 Terminated
Has Results
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Alefacept
25 Completed
Has Results
Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
26 Completed
Has Results
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
Conditions: Graft Versus Host Disease;   GVHD
Interventions: Drug: tacrolimus;   Drug: sirolimus;   Drug: fludarabine;   Drug: busulfex
27 Completed CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
Conditions: Hematologic Malignancy;   AML;   ALL;   CML;   Multiple Myeloma;   NHL;   Hodgkin's Lymphoma
Intervention: Device: CD+8 T cell depletion
28 Completed
Has Results
Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies
Conditions: Hemoglobinopathies;   Sickle Cell Disease;   Thalassemia
Interventions: Drug: Busulfex;   Drug: Fludarabine;   Drug: Alemtuzumab;   Procedure: Stem Cell Transfusion
29 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
30 Completed A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
Conditions: Myelofibrosis;   Myeloid Metaplasia;   Agnogenic Myeloid Metaplasia;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Imatinib mesylate
31 Completed Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
32 Terminated
Has Results
Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation
Condition: Graft-vs-Host Disease
Interventions: Drug: Sirolimus;   Drug: Mycophenolate mofetil;   Drug: Bortezomib
33 Recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
34 Completed
Has Results
Campath in Chronic GVHD
Condition: Chronic Graft-vs.-Host Disease
Intervention: Drug: Alemtuzumab (Campath)
35 Recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
36 Recruiting Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Leukemia, Lymphocytic, Chronic;   Lymphoproliferative Disorders
Intervention:
37 Recruiting Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Conditions: Multiple Myeloma;   Waldenstrom's Macroglobulinemia;   Smoldering Multiple Myeloma;   Lymphoblastic Lymphoma
Intervention:
38 Recruiting A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Multiparametric MRI;   Procedure: Prostate biopsy
39 Not yet recruiting Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Condition: Sickle Cell Disease
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Drug: r-ATG;   Procedure: Bone Marrow Transplant;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Standard of Care
40 Recruiting Gut Decontamination In Pediatric Allogeneic Hematopoietic
Conditions: Hematopoietic Stem Cell Transplantation (HSCT);   Acute GVH Disease
Intervention: Drug: Vancomycin-polymyxin B

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years